(Q61920731)
Statements
A Randomized, Double Blind, Placebo and Active Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Potential Efficacy of a 12-Week Treatment With YM543 in Subjects With Type 2 Diabetes Mellitus (English)
0 references
February 2007
0 references
June 2008
0 references
97
0 references
18 year
0 references
65 year
0 references